Unblemish Dual Intensive Acne Treatment Lotion
FDA Label NDC 14222-2120

14 label sections · Submitted to the FDA by Rodan & Fields · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Rodan & Fields for the product Unblemish Dual Intensive Acne Treatment (NDC 14222-2120). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, otc - do not use, when using this product, stop use and ask a doctor if, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient

Benzoyl peroxide 2.5%

Purpose

Acne treatment

Uses

  • for the treatment of acne
  • helps keep skin clear of new acne blemishes, acne pimples, blackheads + whiteheads

Warnings

For external use only

Otc - Do Not Use

Do not use if you

  • have very sensitive skin
  • are sensitive to benzoyl peroxide

When Using This Product

  • skin irritation may occur, characterized by redness, burning, itching, peeling or possibly swelling. Irritation may be reduced by using the product less frequently or in a lower concentration.
  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
  • avoid unnecessary sun exposure and use a sunscreen
  • avoid contact with the eyes, lips and mouth
  • avoid contact with hair and dyed fabrics, which may be bleached by this product

Stop Use And Ask A Doctor If

  • irritation becomes severe

Otc - Keep Out Of Reach Of Children

Keep out of reach of children. If swallowed get medical help or contact a Poison Control Center right away.

Directions

  • clean the skin thoroughly before applying this product
  • dispense 1-2 pumps from each side. Blend product evenly.
  • cover the entire affected area with a thin even layer one to three times daily, as needed
  • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
  • if bothersome dryness or peeling occurs, reduce application to once a day or every other day
  • do not rinse product off face
  • if going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and ask a doctor.
  • wash hands after application to help avoid staining fabrics

Other Safety Information

Other information store 15-30°C (59-86°F)

Inactive Ingredient

Inactive ingredients allantoin, aloe barbadensis leaf juice, aminomethyl propanol, aqua/eau/water, benzyl alcohol, BHT, biosaccharide gum-1, C13-14 isoalkane, carbomer, ceramide AP, ceramide EOP, ceramide NP, chamomilla recutita (matricaria) flower extract, cholesterol, citronellol, corn starch modified, disodium EDTA, ethoxydiglycol, ethylhexylglycerin, fragrance/parfum, geraniol, glycerin, laureth-7, leuconostoc/radish root ferment filtrate, limonene, linalool, niacinamide, panthenol, PEG-7 glyceryl cocoate, phenoxyethanol, phytosphingosine, polyacrylamide, punica granatum fruit extract, sodium lauroyl lactylate, xanthan gum, yucca glauca root extract

Otc - Questions

Questions? 1-888-995-5656

Principal Display Panel - 45Ml / 1.5 Fl. Oz. Carton Label

RODAN+FIELDS

UNBLEMISH

DUAL INTENSIVE ACNE TREATMENT
Benzoyl Peroxide Lotion

R+F

2 x 22.5 mL /
2 x 0.76 Fl. Oz. U.S.

Principal Display Panel (45mL / 1.5 Fl. Oz. Carton Label)

Principal Display Panel (45mL / 1.5 Fl. Oz. Carton Label)

Principal Display Panel - 45Ml / 1.5 Fl. Oz. Tube Label

RODAN+FIELDS

UNBLEMISH

Dual Intensive Acne Treatment

Benzoyl Peroxide
Lotion

3

Principal Display Panel (45mL / 1.5 Fl. Oz. Tube Label)

Principal Display Panel (45mL / 1.5 Fl. Oz. Tube Label)

* Please review the disclaimer below.